Cue Biopharma, Inc.CUENASDAQ

Revenue (LTM)

$27M

+195.7% YoY

Net Income (LTM)

$-27M

+34.6% YoY

Free Cash Flow

$-22M

Revenue CAGR (5Y)

+54.2%

Marginsdeclining

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	15	1↓91.7%	5↑341.0%	9↑69.2%	27↑195.7%
Gross Profit	17	1↓92.6%	-33↓2719.0%	9↑128.5%	0
Operating Income	-44	-53↓21.8%	-52↑2.0%	-42↑20.4%	-27↑36.0%
Net Income	-44	-53↓20.0%	-51↑4.3%	-41↑19.8%	-27↑34.6%
EBITDA	-45	-50↓11.1%	-46↑8.8%	-38↑18.5%	-27↑29.2%
EPS Diluted	-1.41	-1.49↓5.7%	-1.11↑25.5%	-0.72↑35.1%	-0.28↑61.1%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	64	52↓19.8%	49↓6.0%	22↓53.7%	27↑20.8%
Total Current Assets	68	77↑12.7%	51↓33.3%	25↓51.1%	37↑47.1%
Total Assets	83	91↑9.5%	62↓32.6%	32↓47.7%	42↑31.1%
Total Current Liabilities	13	12↓9.7%	17↑47.9%	14↓19.9%	13↓1.4%
Total Liabilities	18	26↑43.0%	24↓4.5%	15↓39.9%	16↑7.4%
Total Equity	65	66↑0.3%	37↓43.5%	17↓52.8%	26↑51.0%
Total Debt	12	19↑60.7%	15↓23.9%	9↓39.6%	4↓52.7%
Net Debt	-52	-32↑38.3%	-34↓4.7%	-14↑59.8%	-23↓68.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-39	-42↓7.6%	-40↑4.4%	-36↑9.1%	-22↑40.3%
Capital Expenditure	-1	-0↑81.3%	0	-0	-0↓168.2%
Free Cash Flow	-40	-42↓5.6%	-40↑4.8%	-36↑8.9%	-22↑39.9%
Stock-Based Comp	12	9↓17.5%	8↓13.9%	7↓16.3%	5↓30.7%
Net Change in Cash	-10	-13↓21.5%	-3↑75.7%	-26↓740.7%	5↑118.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance